biotech

Medipost Co., a South Korean biotechnology company, has acquired a 39.6% stake in OmniaBio Inc., a Canada-based cell and gene therapy contract devel...

South Korea’s top conglomerate Samsung has unveiled a plan to invest 450 trillion won ($355 billion) over the next five years in strategic sec...

The incoming Yoon Suk-yeol administration will lend extra support to the startup ecosystem – biotech and artificial intelligence firms in part...

FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...

Biotechnology startups in Europe, backed by South Korea's SK Inc., are speeding up their development of next-generation drug candidates by joining h...

Samsung Group’s 150 billion won ($124 million) Life Science Fund launched last year has chosen a leading US gene therapy development company a...

South Korea’s first generation biotech firm Medipost Co. will sell a 30% stake to a private equity consortium, the company announced after W...

South Korea’s biotechnology startup Voronoi Inc. scrapped its plan to go public this month. The new drug developer announced Wednesday it...

South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...

South Korea’s biotechnology startup Voronoi Inc. plans an initial public offering in March to raise up to 130 billion won ($108.4 million).Vor...

EONE-DIAGNOMICS Genome Center Co. ( EDGC ) announced this week it would participate in AI Human Metaverse Project consortium – along with seven ...

CHA Biotech, South Korea’s stem cell therapeutics developer, is set to expand its biomaterials contract development and manufacturing organiza...

MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...

Overseas technology transfers from South Korean biotechs and pharmaceutical manufacturers this year have exceeded 11 trillion won ($9.3 billion), al...

WASHINGTON D.C. -- US-based biotechnology company Moderna Inc. wasn’t a household name until the beginning of last year, when its fate changed...

JW Bioscience Co., a subsidiary of South Korea’s JW Life Science Co., has signed a non-exclusive agreement to transfer its patented technology...

Voronoi Inc., a South Korean biotechnology startup, has clinched a $324 million deal to grant Brickell Biotech, a US clinical-stage pharmaceutical f...

The rise of the platform economy is a global phenomenon. The spread of the coronavirus pandemic has accelerated the use of contactless technology an...

South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...

South Korea’s biotechnology firm Biocorp Co. has produced krill oil containing 61% phospholipids, the highest level in the world, and has begu...

The South Korean government said on Sept. 21 that it will triple the size of the country’s green biotechnology industry over the next decade and...

Mirae Asset Financial Group has invested $28 million in Shanghai-based biotechnology startup JW Therapeutics, about a quarter of $100 million financin...

Mirae Asset Daewoo Co. Ltd. has earned a 150% return on a $15 million investment in German biotechnology firm BioNTech SE in nine months, securing $22...

South Korea’s $25 million biotechnology-themed fund, launched by Meritz Securities Co. Ltd., has earned triple-digit returns on its 2.7 billion ...

KB Investment Co. Ltd., the venture capital arm of KB Financial Group, has invested $10 million in a Swiss biotech start-up firm which recently raised...